5/13
11:22 am
tars
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at HC Wainwright from $57.00 to $61.00. They now have a "buy" rating on the stock.
Medium
Report
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at HC Wainwright from $57.00 to $61.00. They now have a "buy" rating on the stock.
5/12
08:52 am
tars
Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]
Low
Report
Earnings Update: Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance]
5/10
03:41 pm
tars
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at Barclays PLC from $50.00 to $60.00. They now have an "overweight" rating on the stock.
Low
Report
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at Barclays PLC from $50.00 to $60.00. They now have an "overweight" rating on the stock.
5/10
07:49 am
tars
Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Tarsus Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
5/9
05:00 pm
tars
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
Medium
Report
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
5/9
01:20 pm
tars
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at Oppenheimer Holdings Inc. from $59.00 to $61.00. They now have an "outperform" rating on the stock.
Medium
Report
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at Oppenheimer Holdings Inc. from $59.00 to $61.00. They now have an "outperform" rating on the stock.
5/9
12:59 pm
tars
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/8
07:34 pm
tars
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
High
Report
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
5/8
04:23 pm
tars
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements [Yahoo! Finance]
High
Report
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements [Yahoo! Finance]
5/8
04:05 pm
tars
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
Medium
Report
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
5/1
05:00 pm
tars
Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Medium
Report
Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
4/23
08:47 am
tars
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon [Yahoo! Finance]
Medium
Report
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon [Yahoo! Finance]
4/23
08:30 am
tars
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
Medium
Report
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
4/19
07:57 am
tars
Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14% [Yahoo! Finance]
Medium
Report
Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14% [Yahoo! Finance]
4/1
01:42 pm
tars
Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why [Yahoo! Finance]
Low
Report
Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why [Yahoo! Finance]
3/7
08:36 pm
tars
Tarsus Pharmaceuticals: A Strong Launch For An Under The Radar Name [Seeking Alpha]
Medium
Report
Tarsus Pharmaceuticals: A Strong Launch For An Under The Radar Name [Seeking Alpha]
3/7
08:02 am
tars
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at Jefferies Financial Group Inc. from $30.00 to $44.00. They now have a "buy" rating on the stock.
Medium
Report
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) had its price target raised by analysts at Jefferies Financial Group Inc. from $30.00 to $44.00. They now have a "buy" rating on the stock.
3/6
11:35 am
tars
How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91% [Yahoo! Finance]
Low
Report
How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91% [Yahoo! Finance]
3/5
04:43 pm
tars
Tarsus to Participate at Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Tarsus to Participate at Upcoming Investor Conferences [Yahoo! Finance]
3/5
04:30 pm
tars
Tarsus to Participate at Upcoming Investor Conferences
Low
Report
Tarsus to Participate at Upcoming Investor Conferences
3/5
08:50 am
tars
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis [Yahoo! Finance]
Medium
Report
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis [Yahoo! Finance]
3/5
08:30 am
tars
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
Medium
Report
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
3/1
03:01 pm
tars
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates [Yahoo! Finance]
Medium
Report
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates [Yahoo! Finance]
3/1
12:12 am
tars
Tarsus Announces Pricing of $100.0 Million Public Offering [Yahoo! Finance]
Medium
Report
Tarsus Announces Pricing of $100.0 Million Public Offering [Yahoo! Finance]
3/1
12:07 am
tars
Tarsus Announces Pricing of $100.0 Million Public Offering
Medium
Report
Tarsus Announces Pricing of $100.0 Million Public Offering